Emicizumab in tolerized patients with hemophilia A with inhibitors: A single-institution pediatric cohort assessing inhibitor status.

Batsuli, Glaivy; Greene, Amanda; Meeks, Shannon L; Sidonio, Robert F

Batsuli, Glaivy; Greene, Amanda; Meeks, Shannon L; Sidonio, Robert F.

Afiliação

Batsuli G; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta Atlanta GA USA.
Greene A; Department of Pediatrics Emory University Atlanta GA USA.
Meeks SL; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta Atlanta GA USA.
Sidonio RF; Department of Pediatrics Emory University Atlanta GA USA.

Res Pract Thromb Haemost ; 5(2): 342-348, 2021 Feb.

Article em En | MEDLINE | ID: mdl-33733033

Palavras-chave

antibodies; factor VIII; hemophilia A; immune tolerance; pediatrics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google